Colorado Life-Sciences Leaders Celebrated at Annual Awards, with Aron Ralston Delivering a Powerful Message on Resilience
Colorado’s fast-growing life-sciences sector celebrated its most impactful innovators, investors and industry champions this week at the 22nd Annual Awards Celebration. Hosted by the Colorado BioScience Association (CBSA) and presented by AGC Biologics, the event was held at Denver Center for the Performing Arts’ Seawell Ballroom, which glowed with hues of purple and blue.
The sold-out celebration was a reflection of Colorado’s rising national status in biotech, spotlighting the companies and leaders steering statewide momentum.
CBSA leaders emphasized that this year’s honorees represent the full depth of Colorado’s bioscience landscape. Attendees from clinical-stage startups to advanced manufacturing and statewide policy leadership beamed with pride Elyse Blazevich, CBSA President & CEO and President of the Colorado BioScience Institute praised, “Tonight’s honorees show what it means to be Driven. By Science. For Life.”
Top Awards Highlight Expanding Innovation Across Colorado
Company of the Year — Umoja Biopharma
Based in Louisville, Umoja Biopharma, a company pioneering immunotherapy to combat cancer, earned CBSA’s top honor. Their breakthrough work in in vivo cell and gene therapy took the top honor, beating Boulder-based finalist Enliven Therapeutics.
Named one of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech, Umoja secured a $100 million Series C round in 2025. The company also received FDA Fast Track designation for its CD19 in vivo CAR-T program, expanding its strategic footprint with notable investor backing.
Rising Star of the Year — Ambrosia Biosciences
Boulder-based Ambrosia Biosciences took home the Rising Star Award. Founded in 2024, the company quickly raised a $25 million Series A and is pursuing therapeutic breakthroughs in metabolic disease.
Finalists for the highly-coveted award include Aurora-based Entero Track, which is creating minimally-invasive GI-sampling technology; Aurora-based RheumaGen, a company that develops gene-editing approaches for autoimmune disease; and Boulder-based VitriVax, which is creating novel thermostable vaccines.
Deal of the Year — Enveda Biosciences
Enveda Biosciences was honored for achieving a major milestone. The company secured a $150 million Series D round that elevated it to unicorn status. The funding reflects investor confidence in its AI-powered natural-product drug discovery platform.
Additional Awards
Excellence in Manufacturing — Agilent Technologies
Recognized for its sweeping $725 million investment in Colorado’s nucleic-acid manufacturing capacity and contributions to workforce development.
Building Momentum Award — BioMed Realty
Honored for transforming Boulder’s Flatiron Park into a world-class 1-million-square-foot life-sciences innovation district and for launching new support for the region’s quantum-tech ecosystem.
Business Partner of the Year — Metro Denver Economic Development Corporation
Awarded for its ecosystem-building leadership, including spearheading the national “Hub for Health Impact” competitiveness strategy.
Legislators of the Year
Recognized for their policy efforts advancing Colorado’s bioscience economy, State Senators Scott Bright (R-Adams/Weld) and Julie Gonzales (D-Denver), and State Representatives Sheila Lieder (D-Jefferson) and Lori Garcia Sander (R-Larimer/Weld) were awarded Legislators of the Year.
A Keynote That Captivated the Room: Aron Ralston on Resilience and Reinvention
The night’s most powerful moment came from keynote speaker Aron Ralston. The mountaineer’s extraordinary 2003 survival story, in which he self-amputated his arm after being trapped by a boulder in Utah’s Bluejohn Canyon, has become a global symbol of perseverance.
Ralston delivered a stirring address, blending humor, vulnerability and hard-won wisdom. His message centered on the idea that adversity, when met with clarity and courage, becomes a catalyst for personal and collective transformation.
Ralston reflected on decision-making under pressure, the emotional journey that followed his amputation and the years he spent engineering his own prosthetic devices. His reflections deeply resonated with an audience of researchers, founders and innovators. The room could relate to the idea that scientific discovery often emerges from navigating uncertainty and refusing to give up.
“Innovation,” he suggested, “is what happens when you keep moving — even when everything in front of you is telling you to stop.”
“Aron’s story reminds us that perseverance changes what is possible,” said Matt Teter, CBSA Vice President of Partnerships.
“His resilience and clarity in the face of adversity speak directly to the spirit of our life sciences community. We all left the room energized by his example and ready to drive our work forward with renewed focus.”
The mountaineer’s remarks anchored the event in a shared sense of purpose. Attendees were reminded that resilience is a defining ingredient in every scientific breakthrough.
Colorado’s Growing Momentum
CBSA leaders say this year’s awards reflect a turning point. Colorado is seeing record investor interest. With major expansions in manufacturing capacity and multiple large-scale infrastructure projects, the future is bright.
The state’s talent pipeline, including universities, tech corridors and startup ecosystems, is widening the path to scientific prominence.
This year’s honorees illustrate that growth. Statewide advancements in therapeutic and clinical innovation, capital infusions, manufacturing, infrastructure and strong policy and ecosystem alignment have made life-sciences a major economic driver.
Yet significant work remains. Leaders emphasized the need for continued investment, bipartisan policy collaboration, workforce development and scalable manufacturing infrastructure.
An Elegant Night of Recognition
The 22nd Annual Awards Celebration was a declaration that Colorado is ready for the next phase of its bioscience evolution. It is powered by ambition, resilience and a rapidly expanding community of innovators.
Coupled with Ralston’s charged reminder that “we discover who we are when we face what challenges us,” the evening set a forward-looking tone. Colorado’s life-sciences sector is prepared to lead, with a league of talented professionals creating industry-wide change.
About Colorado BioScience Association
CBSA creates co-opportunity for the Colorado life sciences community. It champions a collaborative life sciences ecosystem and advocates for a supportive business climate.
From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy and Workforce Cultivation to make its members stronger, together.
Editor’s note: For more information about CBSA, visit www.cobioscience.com.
